» Articles » PMID: 39057737

Development and Validation of Four Different Methods to Improve MRI-CEST Tumor PH Mapping in Presence of Fat

Overview
Journal J Imaging
Publisher MDPI
Specialty Radiology
Date 2024 Jul 26
PMID 39057737
Authors
Affiliations
Soon will be listed here.
Abstract

CEST-MRI is an emerging imaging technique suitable for various in vivo applications, including the quantification of tumor acidosis. Traditionally, CEST contrast is calculated by asymmetry analysis, but the presence of fat signals leads to wrong contrast quantification and hence to inaccurate pH measurements. In this study, we investigated four post-processing approaches to overcome fat signal influences and enable correct CEST contrast calculations and tumor pH measurements using iopamidol. The proposed methods involve replacing the Z-spectrum region affected by fat peaks by (i) using a linear interpolation of the fat frequencies, (ii) applying water pool Lorentzian fitting, (iii) considering only the positive part of the Z-spectrum, or (iv) calculating a correction factor for the ratiometric value. In vitro and in vivo studies demonstrated the possibility of using these approaches to calculate CEST contrast and then to measure tumor pH, even in the presence of moderate to high fat fraction values. However, only the method based on the water pool Lorentzian fitting produced highly accurate results in terms of pH measurement in tumor-bearing mice with low and high fat contents.

References
1.
Schick F . Simultaneous highly selective MR water and fat imaging using a simple new type of spectral-spatial excitation. Magn Reson Med. 1998; 40(2):194-202. DOI: 10.1002/mrm.1910400205. View

2.
Delli Castelli D, Ferrauto G, Cutrin J, Terreno E, Aime S . In vivo maps of extracellular pH in murine melanoma by CEST-MRI. Magn Reson Med. 2013; 71(1):326-32. DOI: 10.1002/mrm.24664. View

3.
Loi L, Zimmermann F, Goerke S, Korzowski A, Meissner J, Deike-Hofmann K . Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T. Eur J Radiol. 2020; 129:109068. DOI: 10.1016/j.ejrad.2020.109068. View

4.
Crescenzi R, Donahue P, Mahany H, Lants S, Donahue M . CEST MRI quantification procedures for breast cancer treatment-related lymphedema therapy evaluation. Magn Reson Med. 2019; 83(5):1760-1773. PMC: 6982565. DOI: 10.1002/mrm.28031. View

5.
Zhang S, Rauch G, Adrada B, Boge M, Mohamed R, Abdelhafez A . Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot Study. Radiol Imaging Cancer. 2021; 3(5):e200155. PMC: 8489465. DOI: 10.1148/rycan.2021200155. View